The proposed study is designed to assess the effectiveness of treatment with Oxcarbazepine
vs. placebo in childhood/adolescent autism. This is a twelve-week study involving twenty
subjects between the ages of five and seventeen with a diagnosis of autism.
Phase:
N/A
Details
Lead Sponsor:
University of Medicine and Dentistry of New Jersey
Collaborator:
National Alliance for Research on Schizophrenia and Depression